Skip to main content

Table 1 Included studies

From: Overview of systematic reviews of therapeutic ranges: methodologies and recommendations for practice

Author

Drug

Indication

Protocol

Number of studies

Adverse effects

Study design

“drug monitoring” included in search

Information sources

RoB/Quality assessment of studies

Meta analysis

Cooney 2016 [8]

Aminophylline

Asthma

No

12

Yes

No restrictions

No

Medine, CINAHL, Cochrane Central, and Web of Science

Cochrane tool for assessment of risk of bias [35], CASP tool [36]

No

Sparshatt 2009 [10]

Amisulpride

Schizophrenia/schizoaffective disorder

No

10

Yes

No restrictions

No

Embase, Medline and PubMed

None

No

Sparshatt 2010 [14]

Aripirazole

No specific diagnosis

No

8

No

No restrictions

Yes

Embase, Medline, and PubMed

None

No

Knight 2008 [11]

Mycophenolate Mofetil

Transplant patients

No

12

Yes

RCTs, Observational studies

No

Medline, Embase, Cochrane Central, Transplant Library, Clinical trial registries

None

No

Zuk 2009 [15]

Mycophenolate Mofetil

Heart transplant

No

7

No

No restrictions

Yes

Medline Embase

None

No

Bishara 2013 [16]

Olanzapine

Schizophrenia/schizoaffective disorder/bipolar disorder

No

30

Yes

No restrictions

Yes

PubMed, Medline, Embase

None

Yes

Konidari 2014 [9]

Thiopurine

IBD

No

15

Yes

RCTs, Observational studies

Yes

PubMed, Medline, UK national health system database

NICE defined criteria for quality assessment of case series [37]

No

Moreau 2014 [17]

Thiopurine

IBD

Yes

17

No

No restrictions

Yes

Medline, Cochrane Library, DirectScience, and Google Scholar

Nonea

Yes

Osterman 2006 [12]

Thiopurine

IBD

No

12

No

No restrictions

No

Medline, PubMed Plus

None

Yes

Prybylski 2015 [13]

Vancomycin

S. aureus bacteraemia

No

14

No

Observational studies

No

PubMed

None

Yes

  1. RoB Risk Of bias, IBD Inflammatory Bowel Disease, RCT Randomised controlled trial, CENTRAL Central Register of Controlled Trials
  2. aMoreau et al. used the MOOSE consensus statement to assess reporting quality, but do not report the results of their assessment